These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30788904)

  • 21. Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure.
    Pastormerlo LE; Agazio A; Benelli E; Gabutti A; Poletti R; Prontera C; Clerico A; Emdin M; Passino C
    Am J Cardiol; 2015 Aug; 116(4):567-72. PubMed ID: 26089013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction.
    Guazzi M; Labate V; Cahalin LP; Arena R
    Eur J Prev Cardiol; 2014 Jul; 21(7):847-54. PubMed ID: 23382540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).
    Patel RB; Vaduganathan M; Felker GM; Butler J; Redfield MM; Shah SJ
    Am J Cardiol; 2019 May; 123(10):1660-1666. PubMed ID: 30876658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
    Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
    JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.
    Ahmad T; Fiuzat M; Mark DB; Neely B; Neely M; Kraus WE; Kitzman DW; Whellan DJ; Donahue M; Zannad F; Piña IL; Adams K; O'Connor CM; Felker GM
    Am Heart J; 2014 Feb; 167(2):193-202.e1. PubMed ID: 24439980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise training in advanced heart failure patients: discordance between improved exercise tolerance and unchanged NT-proBNP levels.
    Arad M; Adler Y; Koren-Morag N; Natanzon S; Sela BA; Ben Dov I; Shechter M; Schwammenthal E; Freimark D
    Int J Cardiol; 2008 May; 126(1):114-9. PubMed ID: 17651845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
    Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the Degree of Exercise Tolerance in Children After Surgical Treatment of Complex Cardiac Defects, Assessed Using Ergospirometry and the Level of Brain Natriuretic Peptide.
    Mazurek B; Szydlowski L; Mazurek M; Markiewicz-Loskot G; Pajak J; Morka A
    Medicine (Baltimore); 2016 Feb; 95(8):e2619. PubMed ID: 26937900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing.
    Guazzi M; Boracchi P; Labate V; Arena R; Reina G
    J Card Fail; 2012 Apr; 18(4):313-20. PubMed ID: 22464773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum.
    Faxén UL; Lund LH; Orsini N; Strömberg A; Andersson DC; Linde C; Dahlström U; Savarese G
    Int J Cardiol; 2019 Jul; 287():66-72. PubMed ID: 31005415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
    Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
    ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
    DeVore AD; McNulty S; Alenezi F; Ersboll M; Vader JM; Oh JK; Lin G; Redfield MM; Lewis G; Semigran MJ; Anstrom KJ; Hernandez AF; Velazquez EJ
    Eur J Heart Fail; 2017 Jul; 19(7):893-900. PubMed ID: 28194841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2008 Nov; 27(11):1251-6. PubMed ID: 18971099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity.
    Palau P; Núñez G; de la Espriella R; Miñana G; Domínguez E; Lorenzo M; López L; Flor C; Marín P; Bayés-Genís A; Sanchis J; Núñez J
    Obes Res Clin Pract; 2024; 18(3):226-231. PubMed ID: 38866642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Explanation of the variance in quality of life and activity capacity of patients with heart failure by laboratory data.
    Athanasopoulos LV; Dritsas A; Doll HA; Cokkinos DV
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):375-9. PubMed ID: 19940776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Significance of Exercise Pulmonary Hypertension With a Negative Diastolic Stress Test for Suspected Heart Failure With Preserved Ejection Fraction.
    Verwerft J; Stassen J; Falter M; Bekhuis Y; Hoedemakers S; Gojevic T; Ferreira SM; Vanhentenrijk S; Stroobants S; Jogani S; Hansen D; Jasaityte R; Cosyns B; Van De Bruaene A; Bertrand PB; de Boer RA; Gevaert AB; Verbrugge FH; Herbots L; Claessen G
    J Am Heart Assoc; 2024 Aug; 13(15):e032228. PubMed ID: 39028104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of NT-proBNP at rest and peak exercise in patients with impaired left ventricular function.
    Kallistratos MS; Pavlidis AN; Chamodraka ES; Varounis C; Dritsas A; Laoutaris ID; Manolis AJ; Cokkinos DV
    Angiology; 2012 Oct; 63(7):516-21. PubMed ID: 22156406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.